Medical Robotics Market Report 2025

The medical robotics market size has grown rapidly in recent years. It will grow from $14.59 billion in 2024 to $16.86 billion in 2025 at a compound annual growth rate (CAGR) of 15.6%. The growth in the historic period can be attributed to increasing demand for precision and accuracy, increasing acceptance of minimally invasive surgery, growth in chronic diseases, investment in research and development, expanding applications in healthcare.

The medical robotics market size is expected to see exponential growth in the next few years. It will grow to $35.66 billion in 2029 at a compound annual growth rate (CAGR) of 20.6%. The growth in the forecast period can be attributed to consumer demand for improved healthcare, regulatory support and standards, accessibility and affordability, demand for remote surgery and telepresence, integration with AI and machine learning. Major trends in the forecast period include patient-centric robotics development, advancements in surgical techniques, rise in minimally invasive surgeries, growing role in rehabilitation, demand for telepresence and remote surgeries.

The increasing preference for minimally invasive surgery (MIS) is playing a significant role in driving the growth of the medical robotics market. Minimally invasive surgery encompasses a range of techniques, including the use of medical robots, to perform surgical procedures with reduced trauma to the body compared to traditional open surgery. This approach is gaining popularity among patients due to its associated benefits, such as reduced postoperative pain, lower risk of complications, shorter hospital stays, and faster recovery times. For example, research conducted by Johns Hopkins investigators and published in JAMA Surgery has shown that American hospitals could prevent thousands of post-surgical complications and save between $280 million and $340 million annually by opting for more minimally invasive procedures for routine operations involving the appendix, colon, and lungs, as compared to traditional open surgery. Additionally, data from the American Society of Plastic Surgeons indicates that in September 2023, there were 26.2 million minimally invasive and surgical treatments performed in the US. As the demand for minimally invasive surgical techniques continues to rise, driven by patient preferences and the associated clinical and economic benefits, the medical robotics market is expected to experience significant growth. This trend underscores the increasing role of medical robotics in enabling and enhancing minimally invasive surgical procedures, thereby driving advancements in healthcare delivery and patient outcomes.

The rising prevalence of chronic diseases, particularly cardiovascular diseases, is anticipated to drive the growth of the medical robotics market in the coming years. Cardiovascular diseases (CVDs) encompass a range of conditions that impact the circulatory system, which includes the heart and blood vessels (arteries, veins, and capillaries). Medical robots play a crucial role in treating circulatory illnesses by facilitating minimally invasive surgeries, such as robot-assisted cardiac procedures, which enhance accuracy and reduce patient trauma. For instance, a January 2023 report from the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, projects that by 2050, the number of individuals aged 50 and older with at least one chronic illness will increase by 99.5%, rising from 71.522 million in 2020 to 142.66 million. As a result, the growing prevalence of chronic diseases, including cardiovascular conditions, is driving demand for the medical robotics market.

Strategic collaboration between companies is increasingly becoming a prominent trend in the medical robotics market. Companies operating in this industry are engaging in various collaborations to drive the development of new technologies and products. For example, in February 2022, Novanta, a US-based advanced photonics company, announced a strategic collaboration with MassRobotics, a US-based robotics and AI company, aimed at advancing innovations in medical and surgical robotics. As part of this collaboration, Novanta's business units, Celera Motion and ATI Industrial Automation, will work closely with MassRobotics to develop advanced innovations in medical and surgical robotics, with a focus on enhancing robotic productivity and efficiency.

Major companies in the medical robotics market are focusing on innovative products, particularly robotic platforms, to better serve their existing consumers. A robotic solution refers to a comprehensive application or solution that utilizes robotic technology to address specific tasks, issues, or demands. For example, in May 2023, Robocath, a France-based company specializing in medical robotic solutions for heart-related diseases, introduced an innovative robotic platform called the R-One+. The R-One+ robotic system enables interventional cardiologists to perform coronary angioplasties by controlling the devices using a centralized command unit in the cathlab or control room. This approach offers two key advantages: it protects the cardiologist and medical staff from radiation-related risks, and it streamlines and secures the PCI (Percutaneous Coronary Intervention) process. Cardiologists can now perform more precise hand movements in more ergonomic working environments, ultimately benefiting patients. This focus on advanced robotic platforms reflects the industry's commitment to enhancing medical procedures and outcomes through robotic technology.

In April 2023, CardioVentures Inc., a UK-based medical device company, merged with AVRA Medical Robotics Inc. for an undisclosed sum. Following the merger, AVRA Medical Robotics aims to allocate a significant portion of its resources to expanding and reinforcing the operations of SSI-India, which will become the company's indirect majority-owned subsidiary. As part of this transition, the company's name has been changed to SS Innovations International, Inc. AVRA Medical Robotics Inc. is known for developing medical robot software and artificial intelligence.

Major companies operating in the medical robotics market include Johnson & Johnson, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, GE Healthcare, Philips Healthcare, Boston Scientific Corporation, Intuitive Surgical, Smith & Nephew plc, KUKA Roboter GmbH, Varian Medical Systems, Kirby, Omnicell, iRobot Corporation, Globus Medical, Hansen Medical, Renishaw plc, Accuray Inc., Kinova Robotics, Hocoma AG, Titan Medical Inc., Ekso Bionics, TransEnterix Inc., ReWalk Robotics, Houston Medical Robotics, Medrobotics Corporation.

North America will be the largest region in the medical robotics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical robotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical robotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Medical robots are advanced robotic systems used in healthcare settings to improve patient care. They assist in medical procedures, contribute to the development of healthcare technology, and enhance overall healthcare delivery. Medical robotics technology is utilized in surgeries, radiotherapy treatments, rehabilitation therapies, and other medical applications.

In the field of medical robotics, the main product types are surgical robotics systems, rehabilitation robotics systems, and non-invasive radiosurgery systems. Surgical robotics systems utilize computer technologies and robots to assist in performing medical procedures such as laparoscopy, neurosurgery, cardiology, orthopedic surgery, and pharmacy applications. These systems are commonly used in hospitals, clinics, specialty centers, and rehabilitation centers.

The medical robotics market research report is one of a series of new reports that provides medical robotics market statistics, including the medical robotics industry global market size, regional shares, competitors with a medical robotics market share, detailed medical robotics market segments, market trends and opportunities, and any further data you may need to thrive in the medical robotics industry. This medical robotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

The medical robotics market consists of sales of surgical robots / robot-assisted surgery machine, rehabilitation robots, laboratory robots, hospital robots, social robots. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.